Search results for "biotech"

[USA-Harvard] The Anatomy of Innovation: Inside the World’s Premier Forge for Physician-Scientists

[USA-Harvard] The Anatomy of Innovation: Inside the World’s Premier Forge for Physician-Scientists

In a lab filled with robotic arms and the hum of precision engineering, a medical student in a white coat works intently on an anatomy model.
Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms

Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms

From Technical Instruction to Patient-Centered Care “How do you tell a patient they have terminal cancer?” “If a senior surgeon makes a mistake, how...
Why Rokit Healthcare’s Stock Soared Despite Geopolitical Volatility

Why Rokit Healthcare’s Stock Soared Despite Geopolitical Volatility

Rokit Healthcare is capturing significant market attention for its robust momentum. Its stock price has surged 50% over...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum

Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.